Chris H.

BGF is the UK and Irelands most active growth investor, backing ambitious businesses with minority investment to help them scale on their own terms. Since 2011, we have invested more than £5bn in 650+ businesses across every region and sector. Today, with more than £3.5bn in assets under management, we continue to support a range of growing companies across early-stage and growth-stage. Through our 15 offices across the UK and Ireland, were close to the businesses we back, combining local insight with national scale to build trusted partnerships with entrepreneurs and management teams. Beyond investment, our portfolio companies benefit from the expertise of our 200+ strong team, as well as dedicated value creation support spanning talent, operational expertise and our Scale community – including a network of more than 8000+ experienced business leaders, sector specialists and board-level non-executives. Learn more: BGF UK: https://www.bgf.co.uk BGF Ireland: https://www.bgfireland.ie/

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.) BioAgilytix also offers diagnostic testing services at its CLIA-certified, CAP-accredited Boston laboratory. BioAgilytix’s team of highly experienced scientific and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.

Caledonia Private Capital is the direct investment arm of Caledonia Investments and our focus in on acquiring majority or significant minority stakes in privately owned companies, purely based here in the UK. Focused on investing in mid-sized companies with enterprise values of between £100m and £250m, we work with growing, cash‑generative businesses, collaborating with experienced management teams to boost the performance of companies that are already robust and resilient. Sector-agnostic, we apply rigorous investment criteria to identify businesses with a profitable track record and the potential to grow strongly with our support. Flexibility and patience are the bedrock of our philosophy. We think long-term, supporting our portfolio companies and partnering with management teams throughout our ownership to generate lasting, sustainable value. Together, we look to deliver strong capital growth and a running yield throughout the business cycle. "Caledonia Private Capitals record demonstrates the attractiveness of our unique proposition to investee companies: providing enduring capital and support through a long-term partnership". Tom Leader, Head of Caledonia Private Capital Caledonia Private Capital is one of three divisions within Caledonia Investments plc., a London Stock Exchange-listed investment trust with net assets of £2.8bn. www.caledoniaprivatecapital.com

BGF is the UK and Irelands most active growth investor, backing ambitious businesses with minority investment to help them scale on their own terms. Since 2011, we have invested more than £5bn in 650+ businesses across every region and sector. Today, with more than £3.5bn in assets under management, we continue to support a range of growing companies across early-stage and growth-stage. Through our 15 offices across the UK and Ireland, were close to the businesses we back, combining local insight with national scale to build trusted partnerships with entrepreneurs and management teams. Beyond investment, our portfolio companies benefit from the expertise of our 200+ strong team, as well as dedicated value creation support spanning talent, operational expertise and our Scale community – including a network of more than 8000+ experienced business leaders, sector specialists and board-level non-executives. Learn more: BGF UK: https://www.bgf.co.uk BGF Ireland: https://www.bgfireland.ie/

3i is a leading international investment company with two complementary businesses, Private Equity and Infrastructure, specialising in core investment markets in northern Europe and North America. We provide our shareholders with access to the higher growth potential of mid-market unquoted companies. We use our strong balance sheet and our expertise in specific sectors and geographies to realise this potential and aim to generate mid to high teens returns for our shareholders. We back entrepreneurs and management teams of mid-market businesses in Europe and North America. Once invested, we work closely with our portfolio companies to achieve their full potential.